When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm down 1% premarket on publication of mid-stage selinexor data in treatment-resistant multiple myeloma
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics (NASDAQ:KPTI) slips 1% premarket on heels of Phase 2b data on XPOVIO (selinexor), combined with low-dose dexamethasone, in patients with heavily pretreated triple class refractory multiple myeloma (MM). The results were just published in the online edition of the New England Journal of Medicine.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news, Stocks on the move,